Table 1. Prevalence of hepatic complications according to no or mild, moderate, and severe PLD.
| No or mild | Moderate | Severe | P value a | |
|---|---|---|---|---|
| Subjects of complication analysis (n) | 385 | 54 | 22 | |
| Pressure-related complications (%) | ||||
| Leg edema | 15.3 | 46.3 | 71.4 | <0.001 |
| Ascites | 10.6 | 38.9 | 54.5 | <0.001 |
| Hernia | 2.9 | 25.9 | 35.7 | <0.001 |
| Cyst rupture | 0.3 | 1.9 | 9.1 | <0.001 |
| IVC stenosis or thrombosis | 0.3 | 2.7 | 4.5 | 0.002 |
| Biliary dilatation | 0.5 | 5.6 | 4.5 | 0.003 |
| Infection (%) | ||||
| Cyst infection | 1.6 | 11.1 | 18.2 | <0.001 |
| Cholangitis | 0 | 5.6 | 4.5 | <0.001 |
| Others (%) | ||||
| Splenomegaly without CLD | 0.2 | 0 | 0 | 0.678 |
| Caroli disease | 0.2 | 0 | 0 | 0.678 |
a Chi-square test for trend; None or mild PLD, htTLV<1,600 mL/m; Moderate PLD, 1,600≤ htTLV <3,200mL/m; Severe PLD, htTLV≥3,200 mL/m; PLD, polycystic liver disease; IVC, inferior vena cava; CLD, chronic liver disease.